Company Filing History:
2 out of 795 
1 out of 3 Years Active: 2025
Title: Fei Pan: Innovator in Cell Imaging and Microinjection Technologies
Introduction
Fei Pan is a distinguished inventor based in Hong Kong, China. He has made significant contributions to the fields of cell imaging and microinjection technologies. With a total of 2 patents, his work focuses on enhancing the accuracy and efficiency of biological processes.
Latest Patents
Fei Pan's latest patents include a "Method for accurate segmentation of unstained living adherent cells in differential interference contrast images." This innovative method utilizes a first machine-learning model to process original and rotated cell images, improving cell-segmentation accuracy. The process generates multiple sets of predictions for cell instances, which are then refined to produce a precise segmentation map for the original cell image.
Another notable patent is the "Automated system for high-throughput microinjection of adherent cells." This system employs two or more micropipettes to enhance microinjection throughput. A motorized stage optimally visits cells on a Petri dish, minimizing the total distance traveled and increasing efficiency. The system's design addresses unevenness between the focus plane and the moving trajectory, ensuring precise microinjection.
Career Highlights
Fei Pan has worked with prominent institutions such as the City University of Hong Kong and the Hong Kong Centre for Cerebro-cardiovascular Health Engineering Limited. His experience in these organizations has allowed him to develop and refine his innovative technologies.
Collaborations
Fei Pan has collaborated with notable colleagues, including Dong Sun and Shuxun Chen. Their combined expertise has contributed to the advancement of research in their respective fields.
Conclusion
Fei Pan's innovative work in cell imaging and microinjection technologies showcases his commitment to advancing scientific research. His patents reflect a deep understanding of complex biological processes and a drive to improve methodologies in the life sciences.